Shield Therapeutics (STX): Corp Phase IIIb H2H data presented at conference
23 Oct 2019
Morning Note – 23 October 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 23 October 2019
Shield Therapeutics Plc (STX:LON) | 1.5 0 (-3.7%) | Mkt Cap: 11.5m
- Published:
23 Oct 2019 -
Author:
Mark Brewer -
Pages:
3
Shield Therapeutics (STX): Corp Phase IIIb H2H data presented at conference